Tags |
|
|
Links |
|
|
Advice Pool - Alzheimers Disease - Causes, Symptoms and Treatment
Alzheimer's disease is a group disorders involving the parts of the brain that control thought, memory, and language. Alzheimer's disease is becoming tragically common. It is estimated that there are currently 18 million peop
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
le worldwide with Alzheimer’s disease. Dementia is a disease of the nervous system characterized by loss of certain mental abilities. This loss is severe enough to interfere with normal activities and lasts at least six month
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
s. Dementia is the term for the deterioration of brain function that results in loss of memory, reduced language skills, impaired reasoning and behavioural and emotional problems. As the disease develops, a person loses the a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
bility to carry out familiar tasks, to reason, and to exercise judgment. Moods, personality, and ability to communicate may also be affected. People with AD typically die within eight years of their diagnosis. Some individual
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
may die within a year of diagnosis, others may live as long as twenty years.
Alzheimer's disease is progressive, which means that symptoms worsen over time. Language difficulties also are common in people with Alzheimer's d
Alzheimer's disease is progressive, which means that symptoms worsen over time. Language difficulties also are common in people with Alzheimer's d
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
isease. People with Alzheimer's can lose their sense of time and place - they may, for example, get dressed in the middle of the night or walk off and get lost. New surroundings and new people may be confusing. The disease ty
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
pically progresses to the stage where it is difficult for the patient to be understood by others or to understand others, and in the final stages, the patient is bedridden. Free radicals are another factor in the formation of
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
tangles and plaques. Free radicals are very active chemicals that form in the brain and damage brain cells. Chemicals known as antioxidants react with and destroy free radicals. Unfortunately there is no cure for Alzheimer's.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
However, drugs can help to slow down the progression or relieve some symptoms and delay the need for residential care. Other therapies and support are available.
Causes of Alzheimers Disease
The exect causes of alzheimers
Causes of Alzheimers Disease
The exect causes of alzheimers
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
disease are currently not known. Alzheimer's is caused by a loss of brain cells, as well as changes in the cerebral cortex. Free radicals are another factor in the formation of tangles and plaques. Free radicals are very acti
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e chemicals that form in the brain and damage brain cells. Chemicals known as antioxidants react with and destroy free radicals. Another risk factor is heredity. People whose family members have had AD are more likely to deve
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
lop Alzheimer's disease than those whose families do not have this history. People who have hypothyroidism or have experienced head injuries are also at relatively high risk for AD. Environmental factors have sometimes been p
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
roposed as possible causes for Alzheimers disease.
Symptoms of Alzheimers Disease
The earliest symptom of Alzheimer's disease is memory loss. Memory loss by itself is not an indication that a person has Alzheimer's disease.
Symptoms of Alzheimers Disease
The earliest symptom of Alzheimer's disease is memory loss. Memory loss by itself is not an indication that a person has Alzheimer's disease.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Some memory loss is a natural part of growing old. People with Alzheimer's can lose their sense of time and place - they may, for example, get dressed in the middle of the night or walk off and get lost. In early stages of t
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e disease, family or friends may notice changes in behaviour. As the disease progresses, memory loss gets worse and some people have difficulty in learning new skills. Changes in behaviour may become more obvious, with people
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
saying or doing things that are out of character. Some people become depressed because they realise what is happening to them. During the late stages of the disease, people with Alzheimer's may become totally dependent on ot
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
hers for their care. Walking can become difficult and urinary incontinence may develop.
Treatment of Alzheimers Disease
There is currently no cure and virtually no medical treatment for Alzheimer's disease. However, drugs c
Treatment of Alzheimers Disease
There is currently no cure and virtually no medical treatment for Alzheimer's disease. However, drugs c
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
n help to slow down the progression or relieve some symptoms and delay the need for residential care. A type of drug called cholinesterase inhibitors are used for people with moderate Alzheimer's disease. They work by reducin
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
g the breakdown of the neurotransmitter acetylcholine, levels of which are low in Alzheimer's. There are three such drugs available: donepezil (Aricept), rivastigmine and galantamine. Another drug, memantine, was launched for
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
people in the late stages of Alzheimer's. Sometimes anti-depressant medicines are prescribed to help treat the depression that can be associated with Alzheimer's disease. Some people may benefit from anti-psychotic medicines
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/241557/advicepool-Alzheimers-Disease--Causes-Symptoms-and-Treatment.html">Alzheimers Disease - Causes, Symptoms and Treatment</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/241557/advicepool-Alzheimers-Disease--Causes-Symptoms-and-Treatment.html]Alzheimers Disease - Causes, Symptoms and Treatment[/url]
Related Articles:
Flash - The Next Generation Integrated Development Environment
Cisco CCNP / BCMSN Exam Tutorial: Switches, QoS, And Cisco's Networking Model
Wedding Photography: Selecting a Photographer
Bookmark it:
|